GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affymax, Inc. (FRA:A5Y) » Definitions » Shiller PE Ratio

Affymax, (FRA:A5Y) Shiller PE Ratio : (As of May. 15, 2024)


View and export this data going back to . Start your Free Trial

What is Affymax, Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Affymax, Shiller PE Ratio Historical Data

The historical data trend for Affymax,'s Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymax, Shiller PE Ratio Chart

Affymax, Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Affymax, Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Affymax,'s Shiller PE Ratio

For the Biotechnology subindustry, Affymax,'s Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Affymax,'s Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affymax,'s Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Affymax,'s Shiller PE Ratio falls into.



Affymax, Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Affymax,'s E10 for the quarter that ended in Jun. 2014 is calculated as:

For example, Affymax,'s adjusted earnings per share data for the three months ended in Jun. 2014 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2014 (Change)*Current CPI (Jun. 2014)
=0/100.5595*100.5595
=0.000

Current CPI (Jun. 2014) = 100.5595.

Affymax, Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200409 -14.397 80.121 -18.070
200412 -13.130 80.290 -16.445
200503 -17.477 81.555 -21.550
200506 -18.976 82.062 -23.253
200509 -18.838 83.876 -22.585
200512 -27.381 83.032 -33.161
200603 -6.349 84.298 -7.574
200606 -0.008 85.606 -0.009
200609 -0.003 85.606 -0.004
200612 10.553 85.142 12.464
200703 -0.362 86.640 -0.420
200706 -0.462 87.906 -0.529
200709 -0.611 87.964 -0.698
200712 -0.632 88.616 -0.717
200803 -0.663 90.090 -0.740
200806 -0.797 92.320 -0.868
200809 -1.199 92.307 -1.306
200812 -1.243 88.697 -1.409
200903 -1.011 89.744 -1.133
200906 -0.835 91.003 -0.923
200909 -0.665 91.120 -0.734
200912 -0.432 91.111 -0.477
201003 -0.243 91.821 -0.266
201006 0.573 91.962 0.627
201009 -0.374 92.162 -0.408
201012 -0.342 92.474 -0.372
201103 -0.257 94.283 -0.274
201106 -0.243 95.235 -0.257
201109 -0.204 95.727 -0.214
201112 -0.626 95.213 -0.661
201203 0.659 96.783 0.685
201206 -0.709 96.819 -0.736
201209 -0.528 97.633 -0.544
201212 -1.400 96.871 -1.453
201303 -0.548 98.209 -0.561
201306 0.000 98.518 0.000
201309 0.000 98.790 0.000
201312 0.000 98.326 0.000
201403 0.000 99.695 0.000
201406 0.000 100.560 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Affymax,  (FRA:A5Y) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Affymax, Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Affymax,'s Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Affymax, (FRA:A5Y) Business Description

Traded in Other Exchanges
N/A
Address
630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

Affymax, (FRA:A5Y) Headlines

No Headlines